Tim McInerney

Timothy McInerney is Director at Adgero Biopharmaceuticals Holdings, Inc. since 2016.
Managing Director at Castle Hill Capital Partners, Inc. since 2017.
Independent Non-Executive Director at Silence Therapeutics Plc starting 2025.
Director at Corino Therapeutics, Inc. Partner at Riverbank Capital Securities, Inc. since 2007.
Former Chairman at InSite Vision, Inc. from 2008 to 2015.
Director at Repros Therapeutics, Inc. Director at TG Therapeutics, Inc. from 2004 to 2011.
Managing Director at Paramount BioCapital, Inc. from 1992 to 2007.
Director at ZIOPHARM, Inc. in 2005.
Director at Edgemont Pharmaceuticals LLC.
Independent Director at Alaunos Therapeutics, Inc. from 2011 to 2015.
Independent Director at Emisphere Technologies, Inc. Principal at Bear, Stearns & Co., Inc. Principal at Two River Group Holdings LLC.
Education includes undergraduate degree from St. John's University.